Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FF EAI Robotics Ecosystem Inc.QLGN · Entity 7776 | SVP/Chief Medical Officer | July 11, 2022 | August 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FF EAI Robotics Ecosystem Inc.
Report date July 11, 2022 · Filed August 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2032-07-11 | Direct | 102,000 |
Reported balance
After 2022-07-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-07-11 · Grant · Acquired 102,000 · Balance 102,000 F1: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2022 Filed Aug 4, 2022 16:16 UTC | FF EAI Robotics Ecosystem Inc. QLGN · Entity 7776 | GrantStock Option (Right to Buy) · Derivative | 102,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001493152-22-021326 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Underlying: Common Stock · 102,000 shares Expires 2032-07-11 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 06:15 UTC | FF EAI Robotics Ecosystem Inc. QLGN · Entity 7776 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001493152-21-031058 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-05-17 F1 · derivative.exercise_date: Shares underlying the stock option vest over two-plus years in three equal annual installments from the vesting commencement date of May 17, 2021. Read SEC document |
| May 17, 2021 Filed May 18, 2021 06:14 UTC | FF EAI Robotics Ecosystem Inc. QLGN · Entity 7776 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001493152-21-012046 · ownership.xml · derivative · entry 1 ARSHAD TARIQ · CIK 0001861399 · SVP/Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-05-17 F1 · derivative.exercise_date: Shares underlying the stock option vest over three years in three equal annual installments from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.